{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-24T12:23:50.994367+00:00",
  "news": [
    {
      "title": "Will Vertex Pharmaceuticals Incorporated bounce back from current support - 2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOTEhoRTIteTJ6djg3Sm9JaE1qZlh3YzZrRnpxSVhTTkJzMDAyMjdyaU8wbVNmaUZBbUdzdzVPa1Y4Y2NGWG0xYkF5SElSaUNVYUtMX0s0UXd4S2tmZUVIMWdvekpSdXhSUEFoYW8xOG94c01NY2N3djFrTnVkQzJyQnhhSV9sVl9xWFdsc2h6S0ZFb29pb3EzaE5CRHU5VlFhSDdpTVJFYlZJQjRfMWc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxOTEhoRTIteTJ6djg3Sm9JaE1qZlh3YzZrRnpxSVhTTkJzMDAyMjdyaU8wbVNmaUZBbUdzdzVPa1Y4Y2NGWG0xYkF5SElSaUNVYUtMX0s0UXd4S2tmZUVIMWdvekpSdXhSUEFoYW8xOG94c01NY2N3djFrTnVkQzJyQnhhSV9sVl9xWFdsc2h6S0ZFb29pb3EzaE5CRHU5VlFhSDdpTVJFYlZJQjRfMWc?oc=5\" target=\"_blank\">Will Vertex Pharmaceuticals Incorporated bounce back from current support - 2025 Market Sentiment & Reliable Intraday Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">newser.com</font>",
      "published": "2025-10-24T07:25:50+00:00",
      "source": "newser.com"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPcnhRMU5KbmVaV1cyeHFJMWl0ckZjQzNjYlFxTlBTNDd0MDdNMk00ak9RX1Zuelp6M3h4Vk9VYjJJNXI2NHE0QVUzXzgxTzR1WENDXzRQc1lieXh6VzJ2ZFFGWG1vQi1MQ2t2eWEwbFVvRGdEMXB4TUtGdk5xMzJ3bjZJRTZKSnVYelVvUWpmOWxrV1NQYy1ueGhyMA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPcnhRMU5KbmVaV1cyeHFJMWl0ckZjQzNjYlFxTlBTNDd0MDdNMk00ak9RX1Zuelp6M3h4Vk9VYjJJNXI2NHE0QVUzXzgxTzR1WENDXzRQc1lieXh6VzJ2ZFFGWG1vQi1MQ2t2eWEwbFVvRGdEMXB4TUtGdk5xMzJ3bjZJRTZKSnVYelVvUWpmOWxrV1NQYy1ueGhyMA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-22T13:00:04+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Advocacy groups form a buyer's club to obtain generic versions of pricey Vertex cystic fibrosis drug - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOUTZSQmhhSDVuRERlLUNZc3o4SG1USGFJYmIwZ1phQk1Od2FCcHpnbnVVSDloR3dTWGZhbkhBb2lxTXRwOWQ0Yngwb1VSa21yVTlVaXctZ2s4Qjh1V1REd2pIN08xWDRFNTFoWWZEZmhHMTJOYkVvMUoyS2hvSjRqOHFLTC1BRURYUjNLVzVJT2pJUGFScE9Lam04eXcyQnh1UEIwNHZuQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxOUTZSQmhhSDVuRERlLUNZc3o4SG1USGFJYmIwZ1phQk1Od2FCcHpnbnVVSDloR3dTWGZhbkhBb2lxTXRwOWQ0Yngwb1VSa21yVTlVaXctZ2s4Qjh1V1REd2pIN08xWDRFNTFoWWZEZmhHMTJOYkVvMUoyS2hvSjRqOHFLTC1BRURYUjNLVzVJT2pJUGFScE9Lam04eXcyQnh1UEIwNHZuQQ?oc=5\" target=\"_blank\">Advocacy groups form a buyer's club to obtain generic versions of pricey Vertex cystic fibrosis drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-24T01:13:05+00:00",
      "source": "statnews.com"
    },
    {
      "title": "The Best Stocks to Invest $50,000 In Right Now - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPbzBKeU4zMnZza01ZREVLU0ZxSXlvV2F0alIxQTEwQWFkUTF0OW15U1BvTXpOUkRzLUdDMW5vSW5KTjNWaXAxZ1JScVFZcjUzN1JfbWdVaUlrbVhhSVRQS01qWnN3TjlWSGc5VmlhT0U1MVpSZEpicWJsRGZ5SVR0alBrTUJESmZnbVQwVWFFUnlvZmwwTHd4bUhUQTM4QlBMZjFlaHJoX1Y0bmJ6UjdjZlVnTlZjSlRtMkNVUE5ndG9ZMFkwcGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxPbzBKeU4zMnZza01ZREVLU0ZxSXlvV2F0alIxQTEwQWFkUTF0OW15U1BvTXpOUkRzLUdDMW5vSW5KTjNWaXAxZ1JScVFZcjUzN1JfbWdVaUlrbVhhSVRQS01qWnN3TjlWSGc5VmlhT0U1MVpSZEpicWJsRGZ5SVR0alBrTUJESmZnbVQwVWFFUnlvZmwwTHd4bUhUQTM4QlBMZjFlaHJoX1Y0bmJ6UjdjZlVnTlZjSlRtMkNVUE5ndG9ZMFkwcGc?oc=5\" target=\"_blank\">The Best Stocks to Invest $50,000 In Right Now</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-10-24T08:54:50+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex’s quest for a breakthrough in Type 1 diabetes - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5\" target=\"_blank\">Vertex’s quest for a breakthrough in Type 1 diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-10-08T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "A Look at Vertex Pharmaceuticals (VRTX) Valuation Following FDA Rolling Review and Key Kidney Therapy Milestones - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOUmxTRGUtR2dMUTFMcVUxRHF5dHpZdzdoaWtSV3J5MF9zcmNnWnNOdUhoUlJwVGNGcndCTEVEc1JCb1FBWWVOQ3pNeHc2MlotUlFNOFdZaEEzQndkNk9qT19tN013X0Vxb25pMkF2ckR0TkhsQTFKeGtzOTd6Z3NKTEZ6ekdnaVlmUGRRS20waGdRNDAtQW9rYV9fem1yT1ppazJNMk9pcHlXM0dpbEpaVkF4Nzg3OWxSaE1Bd0RpMUtUbmEwc0t0MFlzNmoyQ1EzWllBOVZTWWJEY1pFRkJFMElHZ04xVVJlTEx6TtIB8gFBVV95cUxORWdRSzNvT2xVUjVKNUdaUGZIdnB1LXJEbGhQOVp3aWxHRGFhVDV1ZHY1UFRDNmtTV3lJcVRXSkxPNTRhdk1mbEt1VWtuSzhHWVl4LXFyam9mVG5VTmw2VE1jengzZ2FPcmtWVTQxN1dza0Rhc042eUtXMkdsUXBvZVpFNldHVGt0SXRJLWxmUy1xUW5obWgxalRCM3dVSDNPTWtVSUFOZlJGc0lPQWRyamxYc1ZmbjNXZlpzWWh2bUhmTkdRdXI3NGRqeWE2ME5qTHNZWjdBdGYzcWdNNTNWcjdTaHBYc2E4dFB0N2EwN0hwUQ?oc=5\" target=\"_blank\">A Look at Vertex Pharmaceuticals (VRTX) Valuation Following FDA Rolling Review and Key Kidney Therapy Milestones</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-22T14:31:13+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX) - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-10-23T02:44:41+00:00",
      "source": "Insider Monkey"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-23",
      "close": 422.6300048828125
    },
    "history": [
      {
        "date": "2025-10-15",
        "close": 407.8999938964844
      },
      {
        "date": "2025-10-16",
        "close": 408.6099853515625
      },
      {
        "date": "2025-10-17",
        "close": 416.80999755859375
      },
      {
        "date": "2025-10-20",
        "close": 419.1000061035156
      },
      {
        "date": "2025-10-21",
        "close": 426.2699890136719
      },
      {
        "date": "2025-10-22",
        "close": 426.44000244140625
      },
      {
        "date": "2025-10-23",
        "close": 422.6300048828125
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}